Carroll Financial Associates Inc. Buys 1,097 Shares of Nutrien Ltd (NTR)
Carroll Financial Associates Inc. boosted its stake in shares of Nutrien Ltd (NYSE:NTR) by 75.0% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,559 shares of the company’s stock after buying an additional 1,097 shares during the period. Carroll Financial Associates Inc.’s holdings in Nutrien were worth $135,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Point View Wealth Management Inc. boosted its stake in Nutrien by 0.9% during the fourth quarter. Point View Wealth Management Inc. now owns 26,189 shares of the company’s stock worth $1,231,000 after buying an additional 245 shares during the last quarter. Proficio Capital Partners LLC raised its position in Nutrien by 38.3% in the fourth quarter. Proficio Capital Partners LLC now owns 902 shares of the company’s stock valued at $42,000 after purchasing an additional 250 shares during the period. Usca Ria LLC raised its position in Nutrien by 1.4% in the fourth quarter. Usca Ria LLC now owns 20,676 shares of the company’s stock valued at $972,000 after purchasing an additional 286 shares during the period. Cetera Advisors LLC raised its position in Nutrien by 3.1% in the fourth quarter. Cetera Advisors LLC now owns 9,781 shares of the company’s stock valued at $461,000 after purchasing an additional 293 shares during the period. Finally, CLARET ASSET MANAGEMENT Corp raised its position in Nutrien by 3.7% in the fourth quarter. CLARET ASSET MANAGEMENT Corp now owns 8,583 shares of the company’s stock valued at $403,000 after purchasing an additional 310 shares during the period. 66.09% of the stock is currently owned by institutional investors.
NTR stock opened at $54.02 on Monday. The firm has a market capitalization of $32.62 billion, a P/E ratio of 20.08, a PEG ratio of 1.71 and a beta of 0.79. Nutrien Ltd has a 12-month low of $43.96 and a 12-month high of $58.99.
NTR has been the topic of a number of research analyst reports. BMO Capital Markets upgraded Nutrien from a “market perform” rating to an “outperform” rating in a research report on Tuesday, January 8th. Citigroup reduced their target price on Nutrien from $66.00 to $56.00 and set a “buy” rating on the stock in a research report on Monday, January 7th. Raymond James restated a “strong-buy” rating and issued a $70.00 target price on shares of Nutrien in a research report on Thursday, February 7th. Zacks Investment Research downgraded Nutrien from a “buy” rating to a “hold” rating in a research report on Friday, January 11th. Finally, Barclays restated a “buy” rating on shares of Nutrien in a research report on Sunday, February 10th. Six equities research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $61.69.
COPYRIGHT VIOLATION WARNING: “Carroll Financial Associates Inc. Buys 1,097 Shares of Nutrien Ltd (NTR)” was first posted by Watch List News and is the property of of Watch List News. If you are viewing this story on another website, it was copied illegally and republished in violation of United States & international copyright & trademark law. The original version of this story can be accessed at https://www.watchlistnews.com/carroll-financial-associates-inc-buys-1097-shares-of-nutrien-ltd-ntr/2980533.html.
Nutrien Ltd. produces and markets crop nutrients to agricultural, industrial, and feed customers worldwide. It operates in four segments: Retail, Potash, Nitrogen, and Phosphate and Sulfate. The company offers potash, nitrogen, phosphate, and sulfate products. It also distributes crop nutrients, crop protection products, seeds, and merchandise products through operating 1,700 retail locations.
Further Reading: Why is a lock-up period needed for an IPO?
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.